OraSure Technologies, Inc. (FRA:EP3)

Market Cap	167.44M -41.4%
Revenue (ttm)	107.14M -43.9%
Net Income	-51.34M
EPS	-0.69
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.400
Previous Close	2.400
Day's Range	2.320 - 2.400
52-Week Range	1.800 - 3.780
Beta	n/a
RSI	50.81
Earnings Date	Feb 25, 2026

About OraSure Technologies

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic and specimen collection devices and products in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, an...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2000
• Employees: 501
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EP3

Financial Performance

Financial numbers in USD